168 related articles for article (PubMed ID: 22153341)
1. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
2. Improving tumor/muscle and tumor/blood ratios of
Li S; Chu T
Bioorg Med Chem Lett; 2023 Feb; 82():129154. PubMed ID: 36736496
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
4. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
5. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
7. Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromatics.
Melo T; Hua HA; Ballinger JR; Rauth AM
Biochem Pharmacol; 1997 Sep; 54(6):685-93. PubMed ID: 9310345
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, radiolabeling and biological evaluation of propylene amine oxime complexes containing nitrotriazoles as hypoxia markers.
Huang H; Mei L; Chu T
Molecules; 2012 Jun; 17(6):6808-20. PubMed ID: 22664468
[TBL] [Abstract][Full Text] [Related]
9. ⁹⁹mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation.
Mei L; Wang Y; Chu T
Eur J Med Chem; 2012 Dec; 58():50-63. PubMed ID: 23088932
[TBL] [Abstract][Full Text] [Related]
10. Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.
Zhang X; Su ZF; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 2000; 11(3):401-7. PubMed ID: 10821657
[TBL] [Abstract][Full Text] [Related]
11. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
12. Preliminary studies of 99mTc-BnAO and its analogues: synthesis, radiolabeling and in vitro cell uptake.
Sun X; Chu T; Wang X
Nucl Med Biol; 2010 Feb; 37(2):117-23. PubMed ID: 20152710
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
Kusuoka H; Hashimoto K; Fukuchi K; Nishimura T
J Nucl Med; 1994 Aug; 35(8):1371-6. PubMed ID: 8046496
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Ballinger JR; Kee JW; Rauth AM
J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295
[TBL] [Abstract][Full Text] [Related]
15. Role of NADPH:cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxia.
Melo T; Ballinger JR; Rauth AM
Biochem Pharmacol; 2000 Sep; 60(5):625-34. PubMed ID: 10927020
[TBL] [Abstract][Full Text] [Related]
16. A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells.
Su ZF; Ballinger JR; Rauth AM; Abrams DN; Billinghurst MW
Bioconjug Chem; 2000; 11(5):652-63. PubMed ID: 10995208
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.
Su ZF; Zhang X; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 1999; 10(5):897-904. PubMed ID: 10502359
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
19. The biological characterization of (99m)Tc-BnAO-NI as a SPECT probe for imaging hypoxia in a sarcoma-bearing mouse model.
Hsia CC; Huang FL; Hung GU; Shen LH; Chen CL; Wang HE
Appl Radiat Isot; 2011 Apr; 69(4):649-55. PubMed ID: 21236690
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of [
Ruan Q; Zhang X; Gan Q; Fang S; Zhang J
Bioorg Med Chem Lett; 2020 Nov; 30(22):127582. PubMed ID: 33002601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]